Results 131 to 140 of about 42,265 (195)

Refining the diagnostic accuracy of Parkinsonian disorders using metaphenomic annotation of the clinicopathological literature. [PDF]

NPJ Parkinsons Dis
Massey Q, Nihoyannopoulos L, Zeidman P, Warner T, Bhatia K, Gandhi S, Lambert C.   +6 more
europepmc   +1 more source

Is Dysphagia in Multiple System Atrophy Responsive to Levodopa? Results from a Retrospective Study

Movement Disorders Clinical Practice, Volume 13, Issue 3, Page 683-691, March 2026.
Abstract Background Dysphagia remains a major clinical concern in multiple system atrophy (MSA), and so far, lacks relevant treatment options. Objective To systematically assess levodopa‐responsiveness of dysphagia in MSA. Methods 19 MSA‐patients underwent endoscopic swallowing evaluation in Off‐ and On‐state, following an adapted FEES‐levodopa‐test ...
Florin Gandor, Luise Berger, Vera Jäger, Katharina Demmin, Doreen Gruber, Katja Schimming, Paulina Thimm, Georg Ebersbach, Stefanie Schreiber, Dominic Rowe, Annemarie Vogel   +10 more
wiley   +1 more source

Levodopa exposure and nigral neuroinflammation in parkinsonian disorders: A postmortem study of 63 cases. [PDF]

Sci Rep
Backman EA, Luntamo L, Vahlberg T, Gardberg M, Kaasinen V.   +4 more
europepmc   +1 more source

Ocular Motor Abnormalities in Functional Neurological Disorder: A Video‐Oculography Study

Movement Disorders Clinical Practice, Volume 13, Issue 3, Page 711-722, March 2026.
Abstract Background Functional neurological disorders (FND) can include various sensory, motor or cognitive symptoms. Eye movement recordings, measured through video‐oculography, could serve as biomarkers for characterizing these dysfunctions in FND.
Aude Sangare, Astrid de Liège, Bertrand Gaymard, Sophie Rivaud‐Péchoux, Cécilia Bonnet, Evžen Růžička, Jaromír May, Tereza Serranová, Francine Mesrati, Emmanuel Roze, Marie Vidailhet, Céline Louapre, Lionel Naccache, Béatrice Garcin   +13 more
wiley   +1 more source

Moving beyond the hospital: in-depth characterization of daily-life mobility in patients with atypical Parkinsonian disorders. [PDF]

NPJ Parkinsons Dis
Sidoroff V, Moradi H, Prigent G, Jagusch F, Teckenburg I, Asalian M, Hergenroeder-Lenzner N, Giraitis M, Schoenfeldt-Reichmann ET, Ndayisaba JP, Goebel G, Seppi K, Ionescu A, Krismer F, Benninger D, Winkler J, Eskofier BM, Klucken J, Aminian K, Wenning G, Sapienza S, Gassner H, Raccagni C, MobilityAPP Study Group.   +23 more
europepmc   +1 more source

Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders

Neuroprotection, Volume 4, Issue 1, Page 30-47, March 2026.
The graphical abstract encapsulates the dual neuroprotective mechanisms of statins in neurodegenerative diseases, highlighting both cholesterol‐dependent and cholesterol‐independent pathways. By inhibiting 3‐hydroxy‐3‐methylglutaryl coenzyme A (HMG‐CoA) reductase, statins reduce cholesterol synthesis, leading to altered lipid raft structures that ...
Jun Han Kuan, Roshan S. Raghavan, Dawn Li Wei Koh, Wing Yeng Tan, Igor Iezhitsa, Renu Agarwal   +5 more
wiley   +1 more source

NOTCH2NLC Repeat Expansions in Parkinsonian Disorders: Clinical and Neuroimaging Characteristics. [PDF]

Ann Clin Transl Neurol
Chiang HL, Jih KY, Hsiao CT, Chang FP, Chen JC, Liao YC, Wu YR, Lee YC.   +7 more
europepmc   +1 more source

Atypical parkinsonian disorder

, 2015
Henry Knipe, Rohit Sharma, Daniel Bell
openaire   +1 more source

Re‐conceptualizing Parkinson's disease as a lifelong neurobiological trajectory: A framework for prevention

Neuroprotection, Volume 4, Issue 1, Page 14-29, March 2026.
Three‐panel graphical abstract showing the Lifelong Neurobiological Trajectory framework for Parkinson's disease: (1) Vulnerability pathway (top, red) showing how early adversity → epigenetic dysregulation, neuroinflammation, and mitochondrial dysfunction → ↑ PD risk; (2) Lifespan timeline (middle, purple) spanning prenatal/infancy → childhood ...
Ayodeji Johnson Ajibare, Abraham Olufemi Asuku, Olabode Oluwadare Akintoye   +2 more
wiley   +1 more source

Serious Illness Conversation in the Care of Atypical Parkinsonian Disorders: A Practical Guide for Neurology Clinicians. [PDF]

Mov Disord Clin Pract
Bruno MK, Jiao J, Kramer NM, Ivancic M, Chou C, Shurer J, Carroll T, CurePSP Centers of Care Palliative Care Working Group.   +7 more
europepmc   +1 more source